Intellectual Property Committee. The Parties shall, promptly after the Effective Date, establish an intellectual property committee (the “IP Committee”) comprised of at least one senior patent attorney from each Party, together with other representatives of the Parties as the Parties may determine to be appropriate from time to time, to review and discuss, in each case with respect to FibroGen Patents and Joint Patents, the patent prosecution strategy (including whether and where to file patent applications), Orange Book Listings, applications for patent term extension and notices of infringement, as well as the selection, registration, maintenance and defense of Marks and interest in Third Party intellectual property. The IP Committee will serve solely an advisory purpose and shall not have authority to approve or disapprove any actions with respect to patent filing, prosecution and maintenance under this Agreement.
Intellectual Property Committee. Within thirty (30) days after the Effective Date, ARES TRADING and Intrexon will establish and convene an intellectual property committee (the “IP Committee” or the “IPC”) to evaluate intellectual property issues in connection with the Research Programs and other activities under this Agreement and to provide guidance to the JSC on any such issues. The IPC will be composed of at least one (1) patent attorney from each of ARES TRADING and Intrexon. Activities of the IPC shall include (i) for each Research Plan a draft and proposed Strategic IP Plan to the JSC which may be amended from time to time, detailing at a minimum the countries of filing and a patent filing strategy, such strategy (1) shall be aligned between the Parties to secure maximum protection of Products and Intrexon Platform Technology, and (2) shall in cases where any proposed filing of a Product Specific Patent discloses a species generically covered by an Intrexon Patent or Intrexon Sole Patent covering Intrexon Platform Technology, ARES TRADING and Intrexon will use good faith efforts to coordinate filings with respect to such Patents, (ii) oversee the drafting, filing, prosecution and maintenance of all Patents generated from activities under this agreement in accordance with the Strategic IP Plan and Section 9; and (iii) provide guidance and input into the Research Plans of the Research Programs and Allogeneic Cell Therapy Program based on the patent landscape relevant to the respective Research Programs and consider whether it is necessary to enter into any License agreements with a Third Party pursuant the activities undertaken in the respective Programs. Intrexon will provide to the IPC information related to Intrexon Materials and Intrexon Patents reasonably required or provided to ARES TRADING associated with each of the Research Plans and/or Products for review and discussion at the IPC.
Intellectual Property Committee. 8.3.1.1 The Parties hereby establish an “Intellectual Property Committee” that will be responsible for discussing intellectual property rights relating to Program Inventions. The Intellectual Property Committee will be comprised of [***] appointed by each Party, both of whom shall be full or part time employees of the appointing Party and shall have appropriate authority to make the decisions assigned to the Intellectual Property Committee hereunder. Each of Bayer and Compugen may replace its Intellectual Property Committee representative at any time, upon written notice to the other Party.
Intellectual Property Committee. The Parties shall, promptly after the Effective Date, establish an intellectual property committee (the “IP Committee”) comprised of at least one senior patent attorney from each Party, together with such representatives of the Parties as the Parties may determine to be appropriate from time to time, to review and discuss, in each case with
Intellectual Property Committee. NJIT’s Intellectual Property Committee reviews (1) reports regarding invention disclosures to ascertain whether provisional patent applications should be filed on the disclosures, (2) reports relating to conversion of provisional patent applications into full (non-provisional) patent applications, and
Intellectual Property Committee. 1. The Parties hereby establish an Intellectual Property Committee, as set out in Annex 17.06, to review all issues related to intellectual property that arise from this Agreement. This Committee is also authorized to review and follow the progress of issues that concerned by both parties under the framework of WIPO and WTO.
Intellectual Property Committee. 1 The Parties agree to establish an Intellectual Property Subcommittee to follow up on the provisions of this Chapter.
Intellectual Property Committee. The parties shall set up an Intellectual Property Committee which shall be comprised of one (1) representative from each intervening party. Paragraph 1. The Intellectual Property Committee has the following functions: 1. To define the most appropriate and strategic means to protect the products obtained as a result of the project; 2. To support the parties intervening in the project regarding marketing agreements that may be made based on the results of the project; 3. To inform the parties of the confidentiality obligation, as well as its implications regarding project-related information; 4. To prepare an inventory of the products developed as a result of the project, and to monitor and perform quarterly updates on the inventory; 5. To request from the appropriate persons reports on the intellectual contribution of THE PARTIES regarding the PROJECT'S developments; 6. To look after compliance with legal provisions related to intellectual property; 7. To look after compliance with this agreement; 8. To submit xxxxxxxxx reports to each one of the parties' LEGAL REPRESENTATIVE or whoever is acting on his/her behalf. Paragraph 2. The Intellectual Property Committee shall appoint a secretary who will be in charge of preparing and safeguarding the minutes and documents related to the Committee's functions. Paragraph 3. The Intellectual Property Committee shall call bimonthly meetings, for which minutes shall be prepared and sent to each one of the parties. In witness thereof, the parties sign this intellectual property agreement in the city of on the day of , .
Intellectual Property Committee. 9.2.1 On the Effective Date, the Parties shall establish an intellectual property committee (the “IPC”) to facilitate cooperation between the Parties with respect to intellectual property matters under this Agreement. The IPC shall (a) serve as a forum to discuss all material issues relating to the intellectual property that is the subject of this Agreement and (b) select counsel for, and determine strategy in connection with, the filing, prosecution, maintenance, enforcement and defense of any [**]. [**], which representative shall be duly authorized under their respective internal governance procedures to make the decisions or carry out the activities given to them under this Agreement.
Intellectual Property Committee. Within [***] after the Effective Date, or such other time period as agreed upon by the Parties, the Parties shall establish an intellectual property committee (“Intellectual Property Committee” or “IPC”), consisting of an equal number of representatives from each Party having relevant expertise, to discuss prosecution strategy and coordinate the prosecution, maintenance and enforcement of Joint Collaboration Patents, Product-Specific Patents and Product-Platform Patents, and carry out such other functions as are set forth in ARTICLE 8 and as otherwise may be agreed upon by the Parties. IPC meetings may be held in person or by audio or video conference [***] per Calendar Quarter, or as otherwise agreed upon by the Parties. From time to time, each Party may replace one or more of its members of the IPC by providing prior written notice (which may be by email) to the other Party. The IPC will have no decision-making authority, but will act as a discussion forum between the Parties. In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the IPC. Each Party’s representatives on the IPC and all other individuals attending or participating in discussions and meetings of the IPC on behalf of a Party shall be bound by obligations of confidentiality and non-disclosure that are at least as stringent as the provisions of ARTICLE 12.
